Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00716157 · ClinicalTrials.gov registry record
Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 40
- Enrollment target
NCT00716157: Completed study, sponsored by Thomas Jefferson University.
NCT00716157 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00716157 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
Questionnaire study to observe the incidence and pattern or nausea and vomiting in patients receiving combined chemotherapy and radiation. 83% of patients experience radiation therapy-induced vomiting; significant nausea and vomiting could develop with concurrent chemotherapy despite standard anti-nauseous medication prophylaxis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2004-10 |
| Est. Completion | 2011-09 |
What the finished NCT00716157 record still lists
NCT00716157 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00716157 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00716157 about?
NCT00716157 is a clinical study titled "Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation". Questionnaire study to observe the incidence and pattern or nausea and vomiting in patients receiving combined chemotherapy and radiation. 83% of patients experience radiation therapy-induced vomiting; significant nausea and vomiting could develop with concurrent chemotherapy despite standard anti-n...
What is the current status of trial NCT00716157?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2004-10. Estimated completion is 2011-09.
Who is sponsoring clinical trial NCT00716157?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia